Anzeige
Mehr »
Mittwoch, 25.03.2026 - Börsentäglich über 12.000 News
+2.000% bisher - kommt jetzt der nächste Antimon-Trade? A2 Gold zündet die nächste Stufe!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EURE | ISIN: CA71716W2040 | Ticker-Symbol: G11
Frankfurt
25.03.26 | 08:12
0,001 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
PHARMADRUG INC Chart 1 Jahr
5-Tage-Chart
PHARMADRUG INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0010,01509:01

Aktuelle News zur PHARMADRUG Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.01.Pharmadrug Inc (2): Pharmadrug closes acquisition of 19.9% in Canurta2
05.01.PharmaDrug Inc.: PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring220Toronto, Ontario--(Newsfile Corp. - January 5, 2026) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research,...
► Artikel lesen
03.11.25PharmaDrug To Buy 40% Stake in Canurta, Expanding Botanical Therapeutics Portfolio5
31.10.25Pharmadrug Inc (2): Pharmadrug arranges $445,686 debt restructuring2
31.10.25PharmaDrug announces debt restructuring3
31.10.25PharmaDrug Inc.: PharmaDrug Announces Debt Restructuring328Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
30.10.25Pharmadrug Inc (2): Pharmadrug firms up deal to acquire 40% of Canurta3
PHARMADRUG Aktie jetzt für 0€ handeln
30.10.25PharmaDrug signs definitive agreement to acquire equity interest in Canurta7
30.10.25PharmaDrug Inc.: PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc254Toronto, Ontario--(Newsfile Corp. - October 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
30.07.25PharmaDrug Inc.: PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.784Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
16.06.25PharmaDrug Inc.: PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors502Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
06.06.25PharmaDrug Inc.: PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value430Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1